8.1 KiB
Consultation Agreement — Extended-Dose Pack Study (MOU, Final)
Executed on this ___ day of ________ 2026 at Pune, Maharashtra.
Parties
Party of the First Part: Chest Research And Training Private Limited ("CREST"), a company incorporated under the Companies Act, 2013, registered office at Pune, India (includes successors and permitted assigns).
Party of the Second Part: Dr. ______________________, aged ___ years, residing at ______________________, Registration No. ______________________, registered with the ______________ Medical Council, PAN No. ______________, GSTIN (if applicable) ______________ (the "Consultant" or "Physician"; includes legal representatives, heirs, executors, administrators, and permitted assigns).
CREST and the Physician are individually a "Party" and collectively the "Parties".
Recitals
- CREST has been engaged by Cipla Limited ("Sponsor") to conduct an independent physician opinion survey titled "Physicians' Perceptions of the Impact of an Extended-Dose Pack versus Regular Pack on Adherence to Inhaled Maintenance Medication in Asthma and COPD: A Cross-Sectional Survey" to collect professional medical opinions from practicing physicians.
- The study is intended solely to obtain independent professional opinions through a structured online questionnaire for research, scientific, educational, and analytical purposes, and does not involve promotion, endorsement, or prescription of any pharmaceutical product.
- The Consultant is a duly qualified and registered medical practitioner with the requisite qualifications, experience, and expertise.
- The Consultant has voluntarily agreed to participate and provide independent professional opinions per this Agreement.
1. Purpose
1.1 CREST appoints the Consultant on a non-exclusive basis to participate in the physician opinion survey. 1.2 The Consultant accepts and agrees to provide independent professional opinions strictly in accordance with this Agreement.
2. Scope of Services
The Consultant shall:
a. Participate in the physician opinion survey. b. Complete the online questionnaire of approximately 15–20 questions. c. Respond based solely on independent professional knowledge, experience, and clinical judgment. d. Provide truthful, complete, and unbiased responses. e. Submit the completed questionnaire within the timeline communicated by CREST.
3. Obligations of the First Party
- Provide the Second Party with the survey questionnaire and necessary instructions.
- Conduct the survey in accordance with applicable laws and ethical standards.
- Pay the agreed honorarium, along with applicable GST (if any), subject to statutory deductions.
- Provide reasonable support for completion of the survey.
3A. Obligations of the Second Party
- Complete the survey honestly, independently, and within the prescribed timeline.
- Maintain confidentiality of all study-related information.
- Comply with applicable laws and professional ethics, and obtain necessary approvals if required.
- Disclose any conflict of interest that may affect participation.
- Acknowledge that the honorarium is solely for professional consultation and not for promoting or prescribing any product. The Consultant shall provide independent professional opinion.
- The Consultant is under no obligation to provide favourable opinions regarding any pharmaceutical product.
4. Term and Termination
4.1 Commences on the Effective Date and remains valid until completion of the survey and payment of the honorarium, unless terminated earlier.
4.2 Either Party may terminate by written notice if:
a. the other Party commits a material breach and fails to cure it within fifteen (15) days; b. continuation becomes unlawful; c. the study is withdrawn or cancelled.
Where the Consultant has substantially completed the agreed services before termination, CREST may, at its discretion, pay the honorarium on a proportionate basis.
5. Consideration
5.1 Subject to satisfactory completion of the survey, CREST shall pay a professional honorarium of Rs. 15,000/- (Rupees Fifteen Thousand only). 5.2 Payment shall be made within 15 days from completion of the survey and receipt of all necessary documents.
6. Consultant's Representations
The Consultant represents and warrants that:
6.1 He/she is duly qualified and registered with the appropriate Medical Council. 6.2 Participation is voluntary. 6.3 Responses shall represent his/her own independent views. 6.4 Participation does not violate any employment contract, hospital policy, or applicable law. 6.5 Necessary approvals from his/her employer, if required, have been obtained.
7. Confidentiality
7.1 The Consultant shall maintain strict confidentiality regarding: a. Study protocol; b. Questionnaire; c. Study documents; d. Data received; e. Findings; f. Sponsor identity, if designated confidential; g. Any proprietary information shared by CREST. 7.2 The Consultant shall not disclose confidential information without prior written consent, except where required by law.
8. Data Privacy
8.1 The Consultant consents to CREST collecting, storing, processing, and using personal information solely for conducting the study, making payments, statutory compliance, audit, and publication purposes. 8.2 CREST shall process personal data in accordance with applicable Indian data protection laws. 8.3 Survey responses may be anonymized and aggregated before analysis or publication.
9. Intellectual Property
9.1 All questionnaires, study protocols, databases, reports, publications, statistical analyses, and study documents remain the exclusive property of CREST and/or the study sponsor. 9.2 The Consultant shall not claim ownership over the study materials. 9.3 The Consultant shall not publish or distribute the questionnaire or study results without prior written approval from CREST.
10. Conflict of Interest
The Consultant shall disclose any actual or potential conflict of interest that may affect participation in the study.
11. No Promotional Activity
The Consultant acknowledges that:
a. The engagement is purely for obtaining scientific and professional opinions. b. The Consultant is not engaged to market, advertise, promote, prescribe, recommend, or endorse any pharmaceutical product. c. Participation shall not influence the Consultant's clinical judgment or prescribing practices.
12. Indemnity
12.1 The Consultant shall indemnify CREST against losses arising from: a. breach of this Agreement; b. fraudulent or misleading information furnished by the Consultant; c. violation of applicable laws by the Consultant. 12.2 CREST shall not be responsible for any independent professional opinion expressed by the Consultant.
13. Force Majeure
Neither Party is liable for delay or failure in performance resulting from events beyond reasonable control, including acts of God, pandemics, governmental restrictions, strikes, war, cyberattacks, or natural disasters.
14. Dispute Resolution
14.1 The Parties shall first try to resolve disputes through good-faith discussions. 14.2 If unresolved within thirty (30) days, the dispute is referred to arbitration under the Arbitration and Conciliation Act, 1996. 14.3 Arbitration is by a sole arbitrator appointed by the Party of the First Part. Seat and venue: Pune, Maharashtra. Language: English.
15. Miscellaneous
15.1 No amendment is valid unless in writing and signed by authorised representatives of both Parties. 15.2 Neither Party may assign its rights or obligations without the other's prior written consent. 15.3 Nothing herein creates a partnership, agency, employment, or service-provider relationship. 15.4 This Agreement is the entire understanding between the Parties on its subject matter and supersedes all prior discussions, negotiations, and correspondence.
Signatures (IN WITNESS WHEREOF)
For CREST Private Limited Authorized Signatory — Name: ______ | Designation: ______ | Signature: ______ | Date: ______
Consultant / Physician Dr. ______ | Medical Registration No.: ______ | PAN: ______ | GSTIN (if applicable): ______
Bank Details — Bank Name: ______ | Account Holder: ______ | Account Number: ______ | IFSC: ______
Signature: ______ | Date: ______